Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Sudeep Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:544619NSE Symbol: SUDEEPPHRMP/E(TTM):91.35
ISIN Demat:INE0QPI01025Div & Yield %:0EPS(TTM):8.47
Book Value(Rs):46.4172363Market Cap ( Cr.):8738.84Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 356.73343.76404.00344.95217.89123.01
Excise Duty0.000.000.000.000.000.00
Net Sales356.73343.76404.00344.95217.89123.01
Other Income 8.388.2011.188.083.673.22
Stock Adjustments 20.47-7.5815.562.910.460.53
Total Income385.58344.38430.74355.94222.02126.76
EXPENDITURE :      
Raw Materials 139.04118.74181.72137.6383.7445.69
Power & Fuel Cost7.267.308.079.526.104.90
Employee Cost 26.0620.2260.7913.5511.469.34
Other Manufacturing Expenses 22.9618.9327.6141.6016.5610.97
Selling and Administration Expenses 43.9930.8143.8671.8552.2924.77
Miscellaneous Expenses 5.067.268.265.572.412.49
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure244.37203.25330.31279.71172.5698.16
Operating Profit141.20141.14100.4376.2349.4628.61
Interest 5.683.684.831.630.970.93
Gross Profit135.52137.4695.6074.6048.4927.68
Depreciation6.125.154.834.193.533.07
Profit Before Tax129.40132.3190.7770.4144.9624.61
Tax33.1334.0223.1917.0610.596.05
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.530.210.411.04-0.620.51
Reported Net Profit95.7598.0867.1752.3134.9918.04
Extraordinary Items 0.090.070.000.290.070.00
Adjusted Net Profit95.6698.0167.1752.0234.9218.04
Adjst. below Net Profit -0.94-0.360.050.000.000.00
P & L Balance brought forward321.23223.51156.29102.5767.5849.54
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down416.04321.23223.51154.87102.5767.58
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr9.85696.04476.69371.20248.29128.02
Earnings Per Share(Adj)-Unit CurrNANANANANANA
Book Value-Unit Curr44.012374.561681.071193.96822.76574.46